483
Johnson & Johnson Consumer IncJohnson & Johnson Consumer Inc – FDA 483, Aug 12, 2010
Record Details
An FDA inspection of Neutrogena Corporation in Los Angeles, CA, revealed a significant quality control deficiency. The firm failed to ensure that drug product production and control records were adequately reviewed by the quality control unit before batch release. Specifically, temperature excursions during mixing for Body Clear Body Wash lots were not identified during batch record review.
View Company Profile
ID · 1ad5f0ba-04db-4153-9c1d-1e2d2fedec02
Other documents for Johnson & Johnson Consumer Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.